Heidelberg AppWay

by Heidelberg Engineering  · Based in Germany → — A secure gateway to AI analytics for enhanced diagnostic insights.
Ophthalmology
Website
Claim this tool
Is this the maker? Claim the company →

Contact for pricing
Regulatory Status Disclosed

Overview

Heidelberg AppWay is a secure gateway that provides access to clinical and research ophthalmic applications and AI algorithms, including third-party solutions, for enhanced diagnostic insights. It connects HEYEX 2, Heidelberg Engineering’s image management platform, with various clinical and research applications to consolidate diagnostic insights from both Heidelberg Engineering and third-party providers into a single workflow. The platform aims to enhance precision, simplify processes, and ensure secure, compliant data exchange.

Heidelberg AppWay is designed to support clinicians seeking AI-driven solutions to aid their decision-making and researchers interested in innovative analysis tools. It facilitates the secure transmission of pseudonymized patient data to app providers for AI-powered analysis, with the analyzed data automatically reassigned to the patient upon return. This streamlines workflows by eliminating fragmented systems and reducing manual steps, allowing for the combination of imaging, analytics, and reporting in one place.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Secure gateway to ophthalmic AI applications
  • Integration with HEYEX 2 image management platform
  • Access to third-party AI algorithms and SaaS solutions
  • Secure and compliant data exchange (HIPAA, GDPR)
  • Pseudonymization of patient data during transfer
  • Automated reassignment of analyzed data to patient
  • Streamlined workflow for diagnostic insights
  • Vendor-neutral OCT comparisons
  • Customizable reports
  • Supports clinical and research applications

Use Cases

  • Enhanced diagnostic insights from ophthalmic images
  • Automated triage and disease activity assessment
  • Glaucoma risk assessment
  • Analysis of age-related macular degeneration, diabetic retinopathy, diabetic macular edema, cystoid macular edema, and retinal vein occlusion
  • IVI therapy planning in nAMD
  • Choroidal health analysis from OCT scans

What Physicians Need to Know

Evidence Base (guidelines, literature scope)
Heidelberg AppWay provides a secure gateway to AI analytics and algorithms from various partners, offering insights into diagnostic images for clinical and research applications in ophthalmology. These apps leverage deep learning algorithms for tasks such as earlier detection, biomarker quantification, and diagnostic support across a range of ophthalmic diseases, including age-related macular degeneration (AMD), diabetic retinopathy, diabetic macular edema, cystoid macular edema, retinal vein occlusion, and glaucoma. For example, the RetInSight GA Monitor, accessible via AppWay, is the first GA algorithm approved under EU medical device regulation (MDR) for clinical use, measuring and visualizing photoreceptor degeneration and RPE loss. Another app, deepeyeu00ae TPS, is a predictive AI assistant for IVI therapy planning in nAMD, providing disease activity assessment, biomarker visualization, therapy need prognosis, and treatment trend analysis from OCT scans. Eye2Geneu2122 is an AI-based software that accelerates the genetic diagnosis of inherited retinal diseases by analyzing retinal scans to identify specific genes. This AI system was trained on 58,030 multimodal retinal scans from 2,451 patients with confirmed genetic diagnoses and externally validated on 775 patients from five sites, demonstrating a top 5 prediction accuracy of 83% compared to world-leading experts.
Clinical Validation Studies
Several AI applications available through Heidelberg AppWay have undergone validation. For instance, the RetInSight Fluid Monitor, which quantifies and visualizes fluid dynamics in nAMD, is MDR CE-certified. Altris AI, another partner app, is CE-certified, HIPAA and GDPR-compliant, and FDA-cleared (510K), detecting over 70 pathologies and biomarkers, including glaucoma risk assessment. The Eye2Geneu2122 AI system was trained on a large dataset of multimodal retinal scans with confirmed genetic diagnoses and validated across multiple independent clinical centers, achieving high prediction accuracy. The deepeyeu00ae deepeyeu00ae TPS app, a predictive AI assistant for nAMD, is CE-marked.
Alert Fatigue Management
While the platform itself doesn't explicitly detail alert fatigue management, it aims to streamline workflows and provide deeper insights, which can indirectly reduce the burden of reviewing irrelevant information. The goal is to empower clinicians with data-driven insights to make faster, more precise diagnostic and treatment decisions, potentially leading to more meaningful alerts.
Differential Diagnosis Support
Heidelberg AppWay, through its partner AI applications, offers support for differential diagnoses. Eye2Geneu2122, for example, assists in complex differential diagnoses for inherited retinal diseases by providing in-depth genetic insights from retinal scans. The AI-based apps generally aim to empower physicians to identify disease earlier and differentiate conditions.
Clinical Workflow Integration
Heidelberg AppWay is embedded into the HEYEX 2 image management platform, providing a secure, simple, and seamless gateway for data exchange with ophthalmic apps. This integration allows clinicians to send images from Heidelberg Engineering devices to cloud services for AI-powered analysis, with encrypted analysis reports returned to HEYEX 2 and automatically linked to the correct patient record. The platform supports a drag-and-drop workflow for connecting with app partners. HEYEX 2 itself streamlines clinical workflows with a configurable interface, direct EMR and HIS integration, and automated reports. This allows for centralized patient information and immediate access to images and data.
Decision Audit Trail
Heidelberg AppWay ensures secure and compliant data exchange. Patient information is encrypted and pseudonymized before leaving the local system, and pseudonymization is removed only when the analysis report is safely reassigned in HEYEX 2. This process inherently creates a traceable path for the data and its analysis, contributing to an audit trail.
Physician Tip

Leverage Heidelberg AppWay to access a growing portfolio of specialized AI tools that can provide deeper diagnostic insights from your SPECTRALIS and other ophthalmic imaging devices. Utilize the seamless integration with HEYEX 2 to streamline your workflow, allowing for quick analysis and automated report generation directly linked to patient records. Pay attention to the specific certifications (e.g., CE-marked, FDA-cleared) of individual partner apps to understand their validated clinical use. The platform's ability to provide objective, data-driven insights can support faster and more precise diagnostic and treatment decisions, particularly in complex cases or for early disease detection. Remember that while AppWay facilitates access to these tools, individual app providers are responsible for the content, performance, and compliance of their applications.

Heidelberg AppWay is a vendor-neutral workflow solution integrated with the HEYEX 2 ophthalmic image management platform. It facilitates secure data exchange with a growing ecosystem of third-party SaaS and AI companies, allowing for the integration of diverse ophthalmic apps and AI algorithms. The platform supports DICOM and MONAI for interoperability. This connectivity enables combining imaging, analytics, and reporting in one place, eliminating fragmented systems and reducing manual steps. HEYEX 2 also offers direct EMR and HIS integration for comprehensive patient data management.

Details

Category Clinical Decision Support & Reference, Developer Tools & APIs, Ophthalmology AI
Pricing Contact for pricing
  • Subscription to functionality required; contact app partners for specific app pricing and potential free trials
DeploymentCloud-based infrastructure
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

Heidelberg AppWay, along with its integrated apps like Altris AI, is FDA-cleared (510K). The underlying HEYEX and HEYEX 2 platforms have also received FDA 510(k) clearance for clinical use in image/data management as PACS.
Integrations
EHR Not specified
Specialties Ophthalmology

What the Web Says

Heidelberg AppWay is a workflow solution designed for eye care professionals, providing secure and seamless access to innovative analysis tools and AI algorithms for diagnostic insights in ophthalmology. It integrates with the HEYEX 2 image management platform and partners with various SaaS and AI companies to offer specialized applications for retinal diagnostics, therapeutic monitoring, and optic nerve head analysis.

Overall: Positive

Strengths

  • Secure, simple, and seamless gateway for data exchange with ophthalmic apps.
  • Enhances eye care professionals' access to innovative analysis tools and AI algorithms.
  • Improves quality and workflow of challenging therapeutic tasks in modern ophthalmology, such as managing neovascular AMD.
  • Provides precise identification, localization, and quantification of fluid parameters (IRF, SRF, PED) for optimizing and personalizing therapy.
  • Offers detailed 3D optic nerve head analysis, lamina cribrosa parameters, and glaucoma risk scores.
  • Facilitates secure collaboration with trusted third-party SaaS and AI providers while maintaining patient data privacy through encryption and pseudonymization.

Limitations

  • No specific cons were found in the provided search results regarding Heidelberg AppWay itself.
  • General employee reviews for Heidelberg Engineering (the parent company) mention concerns about work-life balance, pay and benefits, job security, and management.
  • Some Reddit discussions about Heidelberg Spectralis (another Heidelberg Engineering product) versus Zeiss Cirrus mention a preference for Zeiss for glaucoma and a nicer ecosystem, though Heidelberg is preferred for retina.

Based on reviews from: The Ophthalmologist, Heidelberg Engineering (product page), Indeed.com, Reddit, YouTube

Last updated: 2026-10-01

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Heidelberg AppWay

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

Heidelberg Engineering
Heidelberg AppWay gives unprecedented access to GA Monitor, the first and only CE-marked AI-based GA-algorithm for clinical use
Heidelberg AppWay now offers access to RetInSight's GA Monitor, the first AI-based geographic atrophy analysis algorithm approved under EU medical device regulation for clinical use. This integration provides deeper diagnostic insights for managing geographic atrophy.
2023-11
The Ophthalmologist
AI that Empowers: Deeper Diagnostic Insights into Geographic Atrophy and Other Ophthalmic Diseases - The Ophthalmologist
Heidelberg AppWay provides secure and seamless access to clinical and research applications, integrating AI-based insights for various ophthalmic diseases, including geographic atrophy. It is a vendor-neutral workflow solution for a growing number of AI applications.
2023-11
Ophthalmology Times Europe
RetInSight and Heidelberg Engineering partner to implement AI-based geographic atrophy analysis for OCT imaging | Eye Care Network - Ophthalmology Times Europe
Heidelberg Engineering has partnered with RetInSight to integrate its GA Monitor, the first CE-marked AI-based algorithm for geographic atrophy analysis, into Heidelberg AppWay. This collaboration aims to enhance diagnostic capabilities for AMD patients.
2023-11
Association of Optometrists (AOP)
Drivers for change in industry in 2023 - Association of Optometrists (AOP)
Heidelberg AppWay was introduced as a vendor-neutral PACS offering secure access to multiple AI applications, including RetInSight's GA Monitor, which analyzes SPECTRALIS OCT images for geographic atrophy.
2023-12
Heidelberg Engineering
Eye2Gene and Heidelberg Engineering Announce Collaborative Partnership at ARVO 2024
Heidelberg Engineering and Eye2Gene announced a partnership to integrate Eye2Gene's AI algorithm for predicting inherited retinal disease genes into Heidelberg AppWay, aiming to revolutionize diagnostics and personalized treatment.
2024-05
Modern Retina - Ophthalmology Times
AI-powered Eye2Gene uses multimodal imaging to diagnose inherited retinal disease | Eye Care Network - Modern Retina - Ophthalmology Times
Eye2Gene, an AI model for diagnosing inherited retinal diseases, is designed for integration with Heidelberg AppWay, allowing real-time gene prediction from SPECTRALIS scans. This technology aims to expedite genetic testing and support non-specialists.
2025-07
PubMed Central (PMC)
Ten years later: how is AI impacting retina care today? - PMC
This peer-reviewed article discusses the impact of AI in retina care, referencing Heidelberg AppWay as a platform providing access to AI analytics for diagnostic insights.
2025-08
Ophthalmology Times
ARVO 2026: Heidelberg debuts new ophthalmic imaging and data management tech
Heidelberg Engineering showcased updates to Heidelberg AppWay at ARVO 2026, highlighting its role as a cloud-based marketplace and workflow solution within HEYEX 2, providing access to third-party AI analytics.
2026-05

Videos

Product demos, reviews, and walkthroughs for Heidelberg AppWay.

View all on YouTube

Frequently Asked Questions

Heidelberg AppWay is a platform designed to streamline clinical workflows and data management. It leverages AI to automate tasks, analyze medical data for insights, and potentially assist in diagnosis and treatment planning, aiming to improve efficiency and patient care.
Heidelberg AppWay is built with robust security measures and aims to comply with relevant healthcare regulations such as HIPAA and GDPR. It employs data encryption, access controls, and audit trails to protect sensitive patient information and ensure regulatory adherence.
While powerful, the AI in Heidelberg AppWay may have limitations, including potential biases in its training data that could lead to disparities in certain patient populations. Physicians should be aware that AI is a supportive tool and clinical judgment remains paramount, especially in complex or unusual cases.
Pricing models for Heidelberg AppWay typically involve subscription-based tiers, which may vary based on the specific features included, the number of users, and the volume of data processed. It's recommended to contact Heidelberg directly for detailed pricing information tailored to your practice's needs.
Heidelberg AppWay is designed to integrate with various existing EHR systems through standard APIs and protocols. The implementation process typically involves an initial assessment, data migration, system configuration, and staff training to ensure a smooth transition and minimal disruption to clinical operations.
Heidelberg provides comprehensive support and training for physicians and their staff using AppWay. This often includes onboarding sessions, user manuals, online resources, and dedicated technical support to address any questions or issues that may arise during its usage.
Heidelberg often provides case studies and physician testimonials highlighting the effectiveness and benefits of AppWay in various clinical settings. These resources can offer insights into how the platform has improved workflows, enhanced patient care, and contributed to better outcomes in practices similar to yours.

Compare Heidelberg AppWay

VS
ChatGPT vs Heidelberg AppWay
Clinical Decision Support & Reference Adjacent · 65/100
ChatGPT for Healthcare is a broad, general-purpose AI assistant designed to support various clinical and administrative workflows across many specialties, including summarization, documentation, and clinical decision support. Heidelberg…
VS
OpenEvidence vs Heidelberg AppWay
Clinical Decision Support & Reference Adjacent · 60/100
OpenEvidence is a general clinical decision support platform providing evidence-based answers and documentation tools for a broad range of medical specialties. Heidelberg AppWay, conversely, is a specialized gateway…
VS
BriefCase vs Heidelberg AppWay
Clinical Decision Support & Reference Adjacent · 65/100
BriefCase and Heidelberg AppWay both leverage AI for enhanced diagnostic insights and secure data exchange in healthcare. However, BriefCase is a broader AI-powered communication and collaboration solution for…

Related Tools

Cortex
Cortex
Clinical Decision Support & Reference
Cortex Workspace is a secure, HIPAA-compliant AI platform designed to streamline healthcare workflows and enhance decision-making for physicians.
Starts free, then $29/month for individual plan (save 10% annually). other plans: enthusiast ($99/month), business ($349/month), enterprise (contact sales).
SureMediks ProView
SureMediks (Rasimo Systems, LLC)
Clinical Decision Support & Reference
SureMediks is an AI-powered clinical decision support and metabolic health platform that automates care workflows for specialists, providing AI-generated patient summaries, automated chart review, and real-time biometric alerts.
SOAP Health
SOAP Health
Clinical Decision Support & Reference
SOAP Health is a Florida-based startup transforming patient intake with AI-powered diagnosis, offering a comprehensive solution that improves diagnosis accuracy and empowers patients and physicians.
Oxipit ChestLink
Oxipit (part of Sectra group)
Clinical Decision Support & Reference
Oxipit ChestLink is the world's first CE Class IIb-certified autonomous AI application for healthy chest X-ray reporting, capable of identifying normal studies with 99.9% sensitivity. It automates the reporting of normal chest X-rays, reducing radiologist workload and improving efficiency.
KATE AI
Mednition
Clinical Decision Support & Reference
KATE AI is a nurse-built clinical decision support tool for emergency departments that analyzes incoming patients in real-time to flag high-risk cases that standard acuity scoring might miss. It has supported over 5,000,000 patient visits, helping emergency teams deliver safer, faster, and more informed care.
Fee-based, not publicly disclosed.
MCG Health
MCG Health
Clinical Decision Support & Reference
MCG Health provides industry-leading evidence-based guidance and technologies to optimize health outcomes, drive operational efficiency, and achieve cost savings. Their solutions are utilized by thousands of hospitals, a majority of U.S. health plans, and various government health programs.
Contact for pricing

See all Clinical Decision Support & Reference tools →

Suggest an Edit → | Last Verified: 2026-07-01 | First Added: 2026-07-01
AI Tool Finder
AI-powered search. Results may not be comprehensive.